vimarsana.com

Latest Breaking News On - Expands clinical trial sites - Page 1 : vimarsana.com

Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that through its collaboration agreement with a.

Texas
United-states
Genentech-tecentriq
Mark-berger
Kalyn-dabbs
Rodney-varner
Exchange-commission
Linkedin
Drug-administration
Genprex-inc
Prnewswire-genprex-inc
Facebook

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.